We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

142 hedge funds and large institutions have $1.14B invested in Immunogen Inc in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 39 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 11

71% more call options, than puts

Call options by funds: $8.3M | Put options by funds: $4.85M

23% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 39

5% more funds holding

Funds holding: 135142 (+7)

3% more capital invested

Capital invested by funds: $1.11B → $1.14B (+$32.6M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
142
Holders Change
+7
Holders Change %
+5.19%
% of All Funds
4.1%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
19
Increased
48
Reduced
39
Closed
11
Calls
$8.3M
Puts
$4.85M
Net Calls
+$3.45M
Net Calls Change
+$3.18M
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
51
Goldman Sachs
New York
$1.14M -$53.6K -3,402 -4%
RPAM
52
Rhenman & Partners Asset Management
Sweden
$1.1M -$415K -26,298 -26%
PIM
53
Platinum Investment Management
Australia
$1.1M
BA
54
BlackRock Advisors
Delaware
$1.06M +$253K +16,062 +29%
BG
55
BlackRock Group
United Kingdom
$1.06M +$196K +12,431 +21%
MLICM
56
Metropolitan Life Insurance Company (MetLife)
New York
$1.04M
NG
57
NatWest Group
United Kingdom
$1.03M +$152K +9,626 +16%
Natixis Advisors
58
Natixis Advisors
Massachusetts
$972K +$128K +8,145 +14%
AIG
59
American International Group
New York
$954K +$21.8K +1,380 +2%
PP
60
PDT Partners
New York
$907K +$958K +60,769 New
U
61
UBS
Switzerland
$852K +$180K +11,434 +25%
PPA
62
Parametric Portfolio Associates
Washington
$819K +$66K +4,188 +8%
PAM
63
Paradigm Asset Management
New York
$800K -$64.6K -4,100 -7%
American Century Companies
64
American Century Companies
Missouri
$787K -$66.2K -4,200 -7%
Citigroup
65
Citigroup
New York
$785K -$253K -16,052 -23%
DekaBank Deutsche Girozentrale
66
DekaBank Deutsche Girozentrale
Germany
$784K +$63.1K +4,000 +8%
VOYA Investment Management
67
VOYA Investment Management
Georgia
$712K
BACM
68
Blue Arrow Capital Management
New York
$672K +$709K +45,000 New
PCM
69
Prelude Capital Management
New York
$580K +$405K +25,675 +195%
Allianz Asset Management
70
Allianz Asset Management
Germany
$552K -$284K -18,000 -33%
MIG
71
Mariner Investment Group
New York
$549K +$580K +36,800 New
DADC
72
D.A. Davidson & Co
Montana
$533K +$105K +6,691 +23%
TRSOTSOK
73
Teachers Retirement System of the State of Kentucky
Kentucky
$532K -$38.5K -2,440 -6%
SFM
74
Sphera Funds Management
Israel
$515K +$544K +34,500 New
ARTA
75
A.R.T. Advisors
New York
$511K +$540K +34,268 New

IMGN Hedge Fund Activity: Q1 2014 in Review

142 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2014, worth a combined $1.14B — up 2.9% from $1.11B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new IMGN positions and 11 closed out — a net gain of 8 holders — while 48 added to existing stakes and 39 trimmed.

The largest buyer was First Trust Advisors, adding an estimated $16M. The largest seller was Norges Bank, cutting an estimated $12.1M.

  • 142 institutional investors held Immunogen Inc (IMGN) as of Q1 2014, up from 135 in Q4 2013.
  • Funds reported $1.14B of Immunogen Inc stock for Q1 2014, up 2.9% quarter-over-quarter.
  • 19 funds opened new Immunogen Inc positions in Q1 2014 and 11 closed out, a net change of +8 holders.
  • The largest Immunogen Inc buyer in Q1 2014 was First Trust Advisors, an estimated $16M added.
  • The largest Immunogen Inc seller in Q1 2014 was Norges Bank, an estimated $12.1M sold.

Based on aggregated 13F filings for Q1 2014.